chrisvoncsefalvay/vaers-outcomes huggingface dataset:
TIA (diagnosed by neurology), hypertensive crisis, Acute hypokalemia. Hypertensive crisis/spikes were treated with anti-hypertensives and patient monitored for 6 days.  No TPA used as CVA not diagnosed and symptoms were transient - less than 24 hours. Patient does report some residual visual changes
16-years-old patient was given first dose of Moderna Covid-19 vaccine; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16-years-old patient was given first dose of Moderna Covid-19 vaccine) in a 16-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     Concurrent medical conditions included Down's syndrome. Concomitant products included LEVOTHYROXINE and VITAMIN D NOS (VITAMIN D) for an unknown indication.    On 14-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Mar-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16-years-old patient was given first dose of Moderna Covid-19 vaccine). On 14-Mar-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16-years-old patient was given first dose of Moderna Covid-19 vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patient was supposed to receive second dose on 11-Apr-2021 but the nurse refused because of patient's age. The reporter informed that the patient was in risk group and did not have full immunity because of rejection of second dose.
40 minutes post shot - became extremely flush and hot; face and neck redness that lasted about an hr..  8 hrs. post injection had extreme itching in upper body (stomach, arms, back and head).  Also experiencing nausea and headache since onset of itching.  Taking Benadryl, Pepcid and Zyrtec.
Registered Nurse used sterile water instead of 0.9% normal saline to dilute 1 vial of pfizer covid 19 vaccine and administered it to the patient.
Awoke next AM with rash upper arm and thigh - disappeared in one hour. Didn't feel well for 1 wk: nausea, headache, (R) upper arm ache x 1 day. 1-2 wks after injection, entire upper (R) arm started to ache and has continued ever since, keeping me awake at night. Went to Dr on Nov. 10, she prescribed Gabapentin, but I was afraid of its side effects so I have not taken it. I've had to rely on TYLENOL and massage for temporary relief.
rash at site of injection  and c/o diffuse itching all over the body but no other lesions found elsewhere
Symptoms began 2 days ago with mild headache, chills and upper respiratory congestion. She denies any cough, shortness of breath, chest pain, tightness or hemoptysis. starting 10/26/21
Chills; Slight fever; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills) and PYREXIA (Slight fever) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Jan-2021, the patient experienced CHILLS (Chills) and PYREXIA (Slight fever). At the time of the report, CHILLS (Chills) and PYREXIA (Slight fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported.  Treatment for the events unknown.  Limited information regarding the events has been provided at this time and a causal relationship cannot be excluded.; Sender's Comments: Limited information regarding the events has been provided at this time and a causal relationship cannot be excluded
pt c/o chest tightness, hx of chest in last week, took 1 nitro glycerine , appeared to faint with heavy breaths. 1505 bp 130/80, p76,o2sat 97% became diaphoretic nauseated , threw up ,became more alert 911 called O2 applied 1520 bp118/74 p61 o2sat 96% Ambulance arrived  transport to ED
Muscle soreness in left arm-bicep area down to inner elbow joint (includes pain in joint).  Could not raise left arm up without pain.  Used Aleeve for anti-inflammatory and pain relief, also heat pad.  Now states arm is doing much better, but wanted to report.
This spontaneous report was received from a healthcare worker and refers to a 12 month old patient of unknown gender. No information regarding the patient's medical, concurrent conditions and concomitant therapies was provided. On 23-JUL-2015, the patient was vaccinated with improperly stored doses of M-M-R II (lot # J010208, expiration date 23-AUG-2015, exact dose and route of administration were not reported) and VARIVAX (Merck) (lot # J009987, expiration date 12-AUG-2015, exact dose and route of administration were not reported). No adverse effects were reported. No PQC (product quality complaint) was involved. This is one of several reports received from the same source. Additional information has been requested.
A few days after first vaccine sores developed on lips.  Since it was not an immediate reaction it was not considered a vaccine reaction.  Valacyclovir was prescribed.  Taken for two weeks and sores disappeared. When second dose was received the same reaction occurred within hours.  Again took Valacyclovir for 2 weeks and sores disappeared. Not until reaction from second dose was there any clue by me or doctor that it was a reaction to COVID-19 vaccine.
Patient states that didn't feel normal after her second Pfizer vaccine. She was tired in the afternoons and felt like she doesn't breathe properly. In mid June she started to feel occasional chest pain. Around June 30th she had chest pain that she thought she is having a heart attack. She was seen by a cardiologist on July 1st who diagnosed her with Pericarditis acuta and prescribed Azithromycin, Dexamethasone, Omeprazole, Xarelto and Bisocor (BP medicine).
This spontaneous report as received from an unspecified healthcare worker refers to a patient of unknown age and gender. On an unknown date the patient was vaccinated with ZOSTAVAX (route, dosage, dose number and lot number unknown). It was reported that a patient that was indicated for (Merck) VARIVAX received ZOSTAVAX. Additional information has been requested.
The patient experienced pain, swelling and cellulitis at the site of injection the evening of the injection. The reaction became worse and the patient was called in the clinic for an evaluation and antibiotics were ordered.(The clinic called this in because this was the third case of this type of reaction with this lot#).
Cough and mucus in throat; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCTIVE COUGH (Cough and mucus in throat) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Mar-2021, the patient experienced PRODUCTIVE COUGH (Cough and mucus in throat). At the time of the report, PRODUCTIVE COUGH (Cough and mucus in throat) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.
The patient (after making an appointment for and filling out all of the information for the appointment), told me that he already had gotten his Flu shot at a different store after I gave him the flu shot. I then gave him the covid shot, which he was also getting.  The patient did not experience any adverse events as far as I can tell and did not seem concerned at all by this
Pts mother came back and informed technician that child fainted in the parking lot/had a rash/complained of itchy scalp/not feeling well/stomach cramps.
Patient received pfizer vaccine on 3/30/21 and 4/27/21. Presented to ER on 7/18/22. Found to be COVID positive on 7/19/22. presents to er brought in by wife due to confusion. He has a hx of tbi, ich as well. He has been more lethargic as well. He was not taking any of his evening meds which concerned here. Patient is not able to provide any hx currently. In ER COVID was positive. Head CT was negative. UA is pending. He was noted to be febrile with temp of 100.9. Lactic also elevated. Will admit as he is confused and not taking PO. Also needs workup for his fever/lactic acidosis. Placed on ceftriaxone and azithromycin. Discharged on 8/1/22.
Patient tested positive for covid after Covid vaccine; Patient have no taste; Patient have no smell; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Patient tested positive for covid after Covid vaccine), AGEUSIA (Patient have no taste) and ANOSMIA (Patient have no smell) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced AGEUSIA (Patient have no taste) and ANOSMIA (Patient have no smell). On 14-Jan-2021, the patient experienced COVID-19 (Patient tested positive for covid after Covid vaccine). At the time of the report, COVID-19 (Patient tested positive for covid after Covid vaccine), AGEUSIA (Patient have no taste) and ANOSMIA (Patient have no smell) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment medications were provided by the reporter.
When I woke up the day after, the injectionsite was itching fiercely and was red and swollen. The itching continued for 3 days, and the redness and swelling for 12 days. Also the day after, I felt midly nauseated for a short time and then, late in the afternoon, I had a short period where I felt chills. I had a headache and fatigue that both lasted for 2 days.
The form only allows me to list one vaccine date, but in actuality, my problems began after my first dose of the Covid vaccine.  It was only in hindsight that I recognized that an abnormality that started then was related to my more severe symptoms later on.  Details are as follows: I have been vaccinated multiple times in my life, including for Yellow Fever and Rabies, along with all core vaccines, yearly influenza vaccines, etc... I have never experienced a vaccine adverse event in my life.  On 2/12/21, I received my first Covid vaccine (moderna) in my right arm.  I experienced injection site pain, which was more severe than I have experienced before, but which resolved within a couple of days.
Gross hematuria with both doses, each occurring within 1-2 days. No lab tests available to corroborate.
Cellulitic type reaction in right arm 6cm proximal to 8cm distal to injection site. Neatly circumferential.
p/vax mom states that about 3-3:30Pm noticed pt had raised hives/welts;mom called clinic recommended to call MD & given DPH;mom attempted to notify MD couldn't get through;feeling better
received first dose of vaccine 18Mar2021.  Has not received second dose.; This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received first dose of vaccine 18Mar2021.  Has not received second dose.) in a 66-year-old male patient who received mRNA-1273 (batch no. 031a21a) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (unknown route) 1 dosage form. On 18-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received first dose of vaccine 18Mar2021.  Has not received second dose.). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received first dose of vaccine 18Mar2021.  Has not received second dose.) had resolved.        The action taken with mRNA-1273 (Unknown) was unknown.   For mRNA-1273 (Unknown), the reporter did not provide any causality assessments.   Pharmacist is calling for her patient who received his first dose of the Moderna vaccine 43 days ago. His 1st dose was on 18Mar2021 Lot number 031a21a.  No concomitant medication and treatment provided
Information has been received from a physician concerning an approximately 75 year old male who on 18-DEC-2006 received a single dose injection of Zostavax (Oka/Merck). There were no concomitant vaccinations. It was reported that after he had received the vaccination, he developed on 07-DEC-2007, a severe case of shingles. It was reported that he sought unspecified medical attention. Current patient status was not reported. It was reported that the patient had picked up the vaccine from a pharmacy and transported it himself to the physician's office. Follow up information indicated that patient developed shingles in December 2007. The reporter felt that the patient did not get immunity from the vaccine and was not an adverse reaction. Current patient status was not reported. Additional information has been requested.
Right shoulder/arm has extreme pain and lack of strength goes down to the right hand.  Neck and right shoulder blade are extremely painful.  Cannot lift right arm higher than straight out from body.  Impossible to lift overhead.
Patient is a 95 y.o. male patient of MD with history of dementia, TIA, urinary incontinence, HTN, prostate CA who presented to Hospital with weakness and cough.    COVID 19 Virus Infection Generalized Weakness Suspect weakness due to underlying COVID in this 95yo Started on Paxlovid as per ID recs Gentle IVF PT/OT Supportive Care   Elevated Troponin Chronically elevated Pt without chest pain EKG with no ischemic changes   Hypertension Blood pressure has been elevated while here in he hospital.  Wife is reluctant to start on anti hypertensive. Prescribed atenolol on discharge. Wife states she will check his blood pressure at home and give medication if it is high.
This spontaneous report was received from a registered nurse and refers to a female patient of unknown age. The patient's medical history, concurrent conditions and concomitant medications were not reported. On an unknown date, the patient started therapy with unspecified flu vaccine (manufacturer unknown) (dose, strength, route, formulation, lot number and expiry date were not reported) for prophylaxis. Nurse stated that the patient developed acute rheumatological events following the administration of an unspecified flu vaccine (manufacturer unknown). The patient also had osteoarthritis and degenerative joint disease and had "extensive cervical reconstruction" (spinal cord operation). The nurse did not state whether the patient's osteoarthritis, degenerative joint disease and cervical reconstruction occurred before or after the patient received the flu vaccine. The outcome of the events were not reported. Causality between the therapy and the events was not reported. Upon internal review, the event of extensive cervical reconstruction was considered to be medically significant. No further information provided. Follow up information was received on 28-APR-2017, from the reporting nurse regarding the female patient of unknown age with concurrent conditions of acute rheumatological events, degenerative joint disease, osteoarthritis, unspecified neck problems and a history of extensive cervical reconstruction. The nurse stated that the patient was a retired physician and had never been given any Merck vaccine before. The nurse was calling Merck when the patient was considering being vaccinated with ZOSTAVAX in her thigh instead of her arm due to the neck issues. The patient did not receive the vaccine as she wanted to talk to her doctor before being given a live vaccine. There was no issue or event reported. This case has been downgraded. The patient did not experience any adverse reaction and did not receive Merck product (only considered this action). Additional information is not expected.
Headache first day slight difficulty swallowing after 6 hours from the time of injection Chills 1st night Joint Pains 2nd day Muscle Pains 2nd day Lingering headache 2nd day
At 6 hours post vaccination, patient experienced chills, fatigue, low grade fever (100.3)  and migraine.  Those symptoms worsened in severity over the course of the next 12 hours.  Symptoms then started to gradually improve, and were manageable by 24 hours post vaccination At 7 days post vaccination, patient started to develop unexplained bruising on stomach and leg.  These bruises were yellow/brown in color.  Patient also has a headache.
Breakthrough case admission after 2 vaccines Moderna 1/14/21 lot# 012L20A;  Moderna 2/11/21 lot# 039K20A
7cm x 6.5cm erythematous raised lesion around vaccine injection site. Arthus type 3 suspected.
First, sore throat, congested sinus up above my head. I tested positive with a rapid home COVID-19 test and it was positive on 03/21/2023. On 03/23/2023 I called my doctor in the morning. The doctor called in a PAXLOVID prescription, if I needed it. I never filled the prescription. That went on for 5 or 6 days. I drank ginger tea, lemon and honey and lots of sleep. I stayed home for 7 days from work then it was Spring break, After the 10 days, I felt normal, I was just tired. I tested and it was still positive after 10 days. I did not test anymore after that.
Within 18 hours of receiving the vaccine I developed fever, joint pain at multiple locations, raised itchy rash covering my entire trunk and the top of my arms (front and back) - these symptoms lasted for 2-3 days;  additionally,  within 3 days of receiving the vaccine,  I developed a shingles rash at a location where I had had one 2-1/2 years earlier - this rash resolved in about a week.
Severe red rash, hives, drop in blood pressure, and pulse, dizziness, weakness, nausea, faintness.
This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Experienced some achiness for 24 hours) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Concurrent medical conditions included Tuberculosis since 2021 and Ulcerative colitis. Concomitant products included ADALIMUMAB (HUMIRA) for Ulcerative colitis, PREDNISONE from 19-Jul-2021 to January 2022 for an unknown indication. On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN (Experienced some achiness for 24 hours). At the time of the report, PAIN (Experienced some achiness for 24 hours) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Liver function test: liver levels were up Liver levels were up. Concomitant medication also included tuberculosis medication NOS. No treatment information was mentioned. Patient took prednisone for a while, and stopped it. Due to this, patient felt muscles and joint pain and had hurt everyday since withdrawal of prednisone. Patient was also on tuberculosis medication for past nine months and used to take Humira but discontinued. She was about to be finished with the course, but liver levels were up from tuberculosis medication. Once he got the booster, he experienced some achiness for 24 hours. It was unknown if patient was enrolled in a COVID-19 Vaccine Trial.
This spontaneous report was received from an office manager and refers to a patient of unknown age and gender. The patient's pertinent medication history and drug reactions or allergies were not reported. On 23-AUG-2016, the patient was vaccinated with an improperly stored dose of (Oka/Merck) VARIVAX (lot number reported as M012992 and expiration date 14-MAR-2108, dose and route of administration were not reported). Concomitant therapy was not reported. No adverse effects were reported. No product quality complaint (PQC) was involved. That was supported. Additional information has been requested.
Continued Double Vision, migrane for 4 days afterward, flu-like symptoms, injection site (arm) VERY painful for days afterward.
Severe body aches, chills, low grade fever of 100.6, pain in left arm. Periodic pain in ears, head and neck. Lethargy. Symptoms continued for 24 hours and resolved themselves without use of any otc pain meds.
fever, sweating, severe headache, body aches, sore throat, dizziness, felt unstable on his feet.
The chills came on right about 9:30 p.m. Friday night lasting much of the overnight.  Then fever hit.  I had a headache for almost 48 hours (and I never get headaches).  Total fatigue for 36 hours, couldn't do anything except lie down until about noon on Sunday.  Monday morning I was back to normal, maybe just a little fatigued.  All the classic side effect symptoms.
EMPLOYEE REPORTED 11/26/19 SINCE HER VACCINE ADMINISTERED ON 10/8/19 SHE HAS PAIN AND  WEAKNESS TO LEFT ARM AND PAIN WITH RAISING THE ARM. SHE RECEIVED THE VACCINE ON 10/8/19 AND REPORTED THESE SYMPTOMS TO EMPLOYEE HEALTH OFFICE ON 11/26/19 AM. SHE HAS REPORTED SHE PLAN TO SEEK MEDICAL ATTENTION REGARDING THESE SYMTPOMS NOTED.
pt awoke this AM 20AUG97 w/h/a, nausea, upset stomach, fever 100;
27 year old female experienced a syncope following her first vaccine of Moderna COVID19 series. Patient was sitting on mobile vaccination chair inside bus and had a syncope episode that approximately lasted 1 minute. Prior to vaccination, patient stated that she had a history of syncopal episodes after vaccinations or blood draws. Patient stated that she did not have any history of illicit drug use or use of prescribed medications. Patient's vital signs were monitored during the event and following recovery. Emergency services were contacted on behalf of patient and she was monitored by EMS on site. Patient recovered consciousness and was fully aware and oriented to person, time place, and event after recovery from syncope episode. Patient's skin was pale and diaphorretic during initial syncope episode however her skin secretions were minimal after recovery. Patient refused EMS medical transport to hospital after incident. Patient continued to be monitored until she was comfortable to leave on her personal vehicle, which was driven by her mother. Patient agreed not to drive post incident. Patient was encouraged to drink water and obtain plenty of nutrients during her day. Patient was educated to seek further medical examination of symptoms worsened or continued through the day.
In general, my symptoms were like a cold.  I was achy, sinuses hurt, gums hurt and I physically tired.  The same day I tested positive the same day my symptoms began.  I got Paxlovid on the same day, the half-dose.  I got better and better.  As of Tuesday, April 11th, I was still testing positive.  Today I am still tired and I don't feel like I have recovered.
Pt reports pain in arm for 2 weeks after vaccine administration. MD aware, pt will have ultrasound in 2 weeks.
Unknown time of event.  Pt states that last night, he was feeling poorly.  He said that he went to try and go to the bathroom, but couldn't go and that he stumbled back to his bed and called for his wife.  At that time, his wife said she saw his eyes roll back into his head and that he feel to the ground and that his whole body began shaking.  She states that seizure lasted for about 30 seconds.  Pt was incontinent of stool.  He doesn't remember the even and was unconscious for the seizure.
Severe shoulder pain, and arm pain, tenderness in arm, limited range of motion, arm weakness, shoulder stiffness, limitations of daily activities, reaching, driving, and disturbed sleep, going on over 2 months now